Status:
COMPLETED
Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy
Lead Sponsor:
University of Lausanne Hospitals
Collaborating Sponsors:
Lionel Perrier Foundation (Montreux, Switzerland)
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to establish the diagnostic value of O-(2-\[18F\]-fluoroethyl)-L-tyrosine (FET) PET-CT, \[18F\]-fluorocholine (FCH) and magnetic resonance imaging (MRI) combined with magnetic...
Detailed Description
The objectives of the study are: * To demonstrate if the multimodal approach, combining the morphological aspect of the MRI with the metabolic aspect of the tumor with magnetic resonance spectroscopy...
Eligibility Criteria
Inclusion
- Suspicion of intracerebral glioma on MR
- Men of women
- Age \>18, no upper limit as long as a biopsy or intervention is foreseen
Exclusion
- Need of rapid intervention in \<2 weeks
- Previous neurosurgical intervention (biopsy, shunt, etc.) or any other cerebral treatment
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00939315
Start Date
July 1 2009
End Date
January 1 2016
Last Update
January 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Vaudois
Lausanne, CH, Switzerland, 1011